Open original FDA record ↗Recall record
- FDA identifier
- Z-2753-2016
- Company in FDA record
- Anthogyr
- FDA classification date
- Sep 8, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Following a FDA inspection showing that the firm failed to validate the design and process of its implants.
Source facts
- Action
- The firm, Anthogyr, contacted physicians by phone and sent an " URGENT: MEDICAL DEVICE RECALL" notification by mail, dated 06/20/2016, informing users of a recall due to inadequate validation of design and process of implants by the FDA. The notice described the product, problem and actions to be taken. The physicians were instructed to isolate the parts and return any Anthogyr implants from lots subject to recall to Business Area Manager, 247 SouthWest 28th road, Miami, FL 33129;and complete and return the RETURN RESPONSE form by fax to: +33 (0)4 50 93 78 60 or e.mail: j.duthil@anthogyr.com or mail: Anthogyr- Director of Quality & Regulatory Affairs- 2237 avenue- Andre Lasquin-France. The firm stated that they will not market their products in the United States until they obtain validation through 21 CFR Part 820. If you have any questions, call 404-718-9689 or email: jduthil@anthogyr.com or mfoley@anthogyr.com.
- Initiated
- 2016-06-20
- Root cause
- Device Design
- Terminated
- 2017-03-28
- Distribution
- US Distribution to sates of: NC, NY, and OR.
- Recall number
- Z-2753-2016
- Recall status
- Terminated
- CDRH record ID
- 148291
- FDA classified
- 2016-09-08
- Recall event number
- 74722